14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -4.156 14 days ( 69.87 % )
Last Price $0.307 0 %
High/ Low $0.307 - $0.307 41.43%
Chg 7 Days 19.15 % $0.258 $0.307
Chg 30 Days -69.57 % $1.01 $0.307
Chg 12 mos -88.00 % $2.56 $0.307
Trend - 3 mos -40.81 % Width: 735.01 %
Trend - 12 mos -41.79 % Width: 1,889.25 %
Pred. range - 3 mos $0.0661 - $0.552 -78.50 % - 79.54 %
Pred. range - 12 mos $0.0589 - $1.17 -80.83 % - 281.28 %
Short MA avg 3 mos Buy Feb 17, 2023 - 4 days
Long MA avg 3 mos Sell Feb 07, 2023 - 12 days
Short/Long MA avg 3 mos Buy Feb 07, 2023 - 12 days
Short MA avg 12 mos Sell Feb 07, 2023 - 12 days
Long MA avg 12 mos Sell Sep 15, 2022 - 111 days
Short/Long MA avg 12 mos Sell Sep 20, 2022 - 108 days
Pivot Short Buy Feb 22, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Sorrento Therapeutics

Sorrento Therapeutics Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric... SRNE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT